Background

The knee is the most commonly afflicted peripheral joint by OA, resulting in progressive loss of function, discomfort, stiffness, and persistent impairment [1].

The frequency of OA of the knee rises with aging and it is higher in people aged 70 to 74 [2, 3].

Hoffa’s fat pad, also known as infrapatellar fat pad (IPFP), is a distinctive intra-articular, though extra-synovial, structure of the knee, that is situated near to the synovium [4, 5].

IPFP is anatomically made up of subcutaneous fat-like adipose tissue [6] and it has a significant biomechanical function in minimizing the effects of load-generated pressures on the knee joint [7, 8].

In recent years, IPFP has emerged as having a new role in knee osteoarthritis (OA). Knee osteoarthritis, in fact, can be considered a disease of the entire joint, involving not only cartilage but also the meniscus, the subchondral bone, the synovial membrane and the infrapatellar fat pad [9].

For these reasons, morphological measurements of IPFP have recently sparked interest in scientific study as prospective biomarkers for investigating the physiology of healthy tissues, structure–function interactions, and size changes associated with obesity and OA. In some papers, larger IPFP sizes have been linked to decreased knee pain and a lower risk of cartilage deterioration [10]. Indeed, there are correlations between quantitative cartilage and Hoffa's fat pad morphological alterations, implying that IPFP volume is deleterious to cartilage deterioration. However, a larger amount of IPFP was seen in persons with symptomatic and radiographic OA of the knee compared to asymptomatic controls with no radiographic evidence of OA [11].

MRI is a fundamental tool for the study of knee osteoarthritis, and in particular, for the quantitative and qualitative evaluation of the Hoffa fat pad, as it has signal characteristics that differentiate it from adjacent structures.

Indeed, IPFP signal intensity in MRI in OA patients was found to be substantially connected with knee structural abnormalities (such as knee cartilage volume) [12, 13]. A study on the elderly before the onset of knee OA discovered that changes in IFP signal intensity were related to the abnormal structure of the knee joint and clinical symptoms cross-sectionally and longitudinally, implying that IFP signal intensity is an important imaging marker of knee OA.

Given the link between IPFP volume and knee OA, an age-related joint illness, this study aims to use sagittal MRI sequences to assess the dimensional changes of the Hoffa fat pad to aging in both sexes.

Methods

Data source and subjects

Data used in this paper were obtained from the Osteoarthritis Initiative (OAI) database. OAI is a multi-center, longitudinal cohort study on knee OA carried out by four American sites (the Ohio State University, Memorial Hospital of Rhode Island, the University of Pittsburgh, University of Maryland and Johns Hopkins University) which recruited patients between February 2004 and May 2006 (Fig. 1).

Fig. 1
figure 1

Infrapatellar fat pad in the knee joint

In this study, 217 patients (108 men and 109 women) between the ages of 40 and 79 were divided into four groups according to their decade of age (40–49 years; 50–59 years; 60–69 years; 70–79 years), and the sagittal thickness of the Hoffa's fat pad was examined in each group.

Image acquisition and analysis

Images were acquired using a 3T Magnetom Trio magnet (Siemens Healthcare Erlangen, Germany) and a quadrature knee coil. The thickness of IPFP was determined using a sagittal intermediate-weighted fat-suppressed turbo spin-echo sequence, IW TSE (time of repetition = 3200 ms, time of echo = 30 ms, slice thickness 3.0 mm; in plane resolution 0.36 mm × 0.36 mm). To get the optimum contrast between the IPFP and surrounding tissue in each image, brightness, intensity, contrast, and gray value restrictions were adjusted.

The maximal sagittal thickness (depth) of IPFP, from the anterior to posterior surface, was manually measured for each patient, both for the right knee and for the left knee, drawing a line perpendicular to the patellar tendon, as published in our previous work [14] (Figs. 2, 3).

Fig. 2
figure 2

MRI image of Infrapatellar fat pad in the knee joint

Fig. 3
figure 3

Measurement of IPFP sagittal thickness (for this figure, all the authors Giovanni Ricatti, Nicola Veronese, Ilaria Gangai, Mariateresa Paparella, Valentina Testini, Giuseppe Guglielmi have given the permission to publish this figure for both the print and online format. This figure is present in the article Ricatti G, Veronese N, Gangai I, Paparella M, Testini V, Guglielmi G. Hoffa's fat pad thickness: a measurement method with sagittal MRI sequences. Radiol Med. 2021 Jun;126(6):886–893. https://doi.org/10.1007/s11547-021-01345-9. Epub 2021 Mar 27. PMID: 33,772,711; PMCID: PMC8154775

Two distinct blinded observers with a combined 3 years of experience conducted all of these measurements; the intra-observer and inter-observer reliability were assessed in our prior study [14].

Statistical analysis

After ensuring that the continuous variables were normal, they were evaluated in terms of means and standard deviation (SD). For categorical relative frequencies (%) were reported. For examining probable gender associations, parametric univariate tests (p-values referenced to Fisher exact for frequencies and t-test for means) were performed. In order to assess whether IPFP sagittal thickness, across all participants (men and women), was related to age we used an ANOVA (Analysis of Variance) test, while the p-values were reported as p for trend.

Finally, the association between age and IPFP sagittal thickness was analyzed using a simple linear correlation analysis.

All analyses were performed using the SPSS 20.0 for Windows (SPSS Inc., Chicago, Illinois). All statistical tests were two-tailed, and statistical significance was assumed for a p-value < 0.05.

Results

Overall, 217 individuals (108 males and 109 females) aging a mean of 57.3 years (SD: 10.4; range: 40–79) were included. The subjects performed MRI of both knees.

Hoffa's fat pad thickness was observed to differ significantly between males and females for both knees, being significantly higher in males compared to females (p < 0.0001).

Table 1 shows the mean thickness of Hoffa's fat pad by gender: at the right knee, in males, this parameter was 33.62 ± 3.00 mm in subjects aged between 40 and 49 years vs. 28.67 ± 1.76 mm in those aging more than 70 years (p for trend < 0.0001). A similar finding was present for left knee. In females aged between 40 and 49 years, the mean thickness of Hoffa’s fat pad was 29.00 ± 1.64 mm vs. 25.96 ± 1.96 mm in females older than 70 years. A similar trend was observed for left knee (Table 1).

Table 1 Mean and standard deviation of Hoffa’s fat pad, by gender

Using a linear correlation analysis, increasing age was associated with a significant decline in mean thickness of Hoffa's fat pad at both knees (R = -0.46; p < 0.0001).

Discussion

Knee osteoarthritis is a complex, painful and disabling pathology. Although patient education, exercises, a change in lifestyle and analgesics should all be included in the initial course of treatment, total joint replacement with an arthroplasty is currently the only successful option for patients with clinically disabling knee osteoarthritis [15]. Since the life expectancy of the population is constantly increasing, the prevalence of knee osteoarthritis is also destined to grow in the next years, as this disease is closely related to aging [16]. Therefore, the understanding of the etiopathogenesis of OA and in particular of the pain mechanisms represents a priority objective for identifying new therapeutic targets, in particular in order to manage pain induced by knee osteoarthritis. It is understood that Hoffa's fat pad serves as a local source of inflammatory mediators, including a range of cytokines and adipokines, including leptin and adiponectin [17,18,19,20,21].

It was also observed that patients with advanced OA had a high degree of fibrosis of Hoffa's body, a process related to the fact that fibrosis can aid repair in the healing process of tissues after injury [22]. Indeed, some studies have evaluated the possible correlation in the increase in IPFP fibrosis and the degree of joint damage [21, 23].

Furthermore, the activation of the inflammatory process also plays an essential role in painful symptoms: in fact, patients with KOA (knee osteoarthritis) who have an increased IPFP volume tend to have symptomatic OA [24, 25]. In individuals with KOA, particular cartilage autoantigens produced can activate immune cells, which then secrete a variety of cytokines and adipokines in response to the local inflammatory state [26].

MRI is essential for getting quantitative information on IPFP in patients with OA, providing direct proof of IPFP involvement in the etiology of KOA.

With our study, we would like to demonstrate a correlation between dimensional variations of the IPF and aging. Moreover, also another study showed a decrease in IPFP volume in moderate and end-stage OA compared to controls as well as a difference in IPFP hypointense signal [36]. Surprisingly, no variation in suprapatellar fat pad was identified between groups, suggesting IPFP's unique involvement in OA [27]. Additionally, it appears that a higher maximum sagittal cross-sectional area of the Hoffa's fat pad is beneficial for avoiding structural alterations and knee pain [25, 28, 29].

However, this constitutes only a starting point for further assessments that may be addressed in the future in other studies, such as the relationship between the serum level of cytokines and adipokines and the size and signaling characteristics of IPFP in MRI; how the characteristics of IPFP in MRI are correlated with the symptoms of OA, even after drug therapy; how MRI features of IPFP can represent an early marker of OA development.

The role of MRI is and will therefore be fundamental not only for the diagnosis of osteoarthritis, but also for the follow-up during therapy and for the prevention of the pathology, being able to also use it as a screening in patients at risk.

Limitations of this study are that it is the retrospective, the limited number of operators (only 2); moreover, the study only included patients with knee osteoarthritis; consequently, it could be valuable in future studies to compare the dimensional variations of Hoffa's fat pad between osteoarthritic and healthy patients.

Conclusions

The study shows that with aging Hoffa’s fat pad, for both male and female patients affected by knee osteoarthritis, undergoes a progressive thinning, detectable by measuring its thickness on sagittal MRI sequences.

This work represents a start point for further studies in the future: the mechanisms underlying the role of Hoffa's fat pad in the symptoms of knee osteoarthritis and in the degenerative processes of articular cartilage; the association between serum levels of various adipokines and the properties of Hoffa's fat pad as measured by MRI; how the characteristics of Hoffa's fat pad on MRI change after therapeutic interventions for osteoarthritis; whether the characteristics of Hoffa's fat pad can be used as a biomarker for imaging of knee osteoarthritis in general; and whether local fatty tissues in other joints are related to joint pain.